Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308187730> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W4308187730 endingPage "622" @default.
- W4308187730 startingPage "616" @default.
- W4308187730 abstract "Non-responsive celiac disease (NRCD) is defined as patients having persistent symptoms and enteropathy (Marsh 3 histology) suggestive of active celiac disease (CeD), after following a gluten-free diet (GFD) for at least 12 months. NRCD is suggested to affect 15% of children with CeD but data are limited and there is no research to date describing treatment of children with this condition. The aim of this study was to describe our center's approach to identifying and treating NRCD with budesonide and the Gluten Containing Elimination Diet (GCED).We performed a retrospective, single center analysis over a 5-year period of patients with CD less than 18 years of age (inclusive) who underwent treatment for persistent symptoms and enteropathy despite following a GFD.We identified 22 patients with NRCD. Thirteen were treated with the GCED for 3 months with 46% achieving both histological and symptomatic resolution. Nine patients were treated with budesonide (6-9 mg), with 89% achieving both symptomatic and histologic resolution after a median 3-month treatment course. Further, 67% of patients who responded to the GCED and 100% of patients who responded to budesonide remained in remission for at least 6 months following treatment transition back to exclusive GFD.The GCED and budesonide can provide benefit for NRCD. Most patients with NRCD can return to a GFD after 3 months of treatment." @default.
- W4308187730 created "2022-11-09" @default.
- W4308187730 creator A5017368763 @default.
- W4308187730 creator A5046930712 @default.
- W4308187730 creator A5057116503 @default.
- W4308187730 creator A5008234338 @default.
- W4308187730 date "2022-08-22" @default.
- W4308187730 modified "2023-09-25" @default.
- W4308187730 title "Budesonide and the Gluten Containing Elimination Diet as Treatments for Non-responsive Celiac Disease in Children" @default.
- W4308187730 cites W1967357905 @default.
- W4308187730 cites W1994246726 @default.
- W4308187730 cites W2020953967 @default.
- W4308187730 cites W2071838153 @default.
- W4308187730 cites W2081288493 @default.
- W4308187730 cites W2101919416 @default.
- W4308187730 cites W2105394907 @default.
- W4308187730 cites W2148072458 @default.
- W4308187730 cites W2156197620 @default.
- W4308187730 cites W2601320624 @default.
- W4308187730 cites W2619612092 @default.
- W4308187730 cites W2747875205 @default.
- W4308187730 cites W2766487326 @default.
- W4308187730 cites W2907463056 @default.
- W4308187730 cites W2924586325 @default.
- W4308187730 cites W2996220874 @default.
- W4308187730 cites W2998877261 @default.
- W4308187730 cites W3040957239 @default.
- W4308187730 cites W3128648179 @default.
- W4308187730 cites W3140098708 @default.
- W4308187730 doi "https://doi.org/10.1097/mpg.0000000000003596" @default.
- W4308187730 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36305882" @default.
- W4308187730 hasPublicationYear "2022" @default.
- W4308187730 type Work @default.
- W4308187730 citedByCount "0" @default.
- W4308187730 crossrefType "journal-article" @default.
- W4308187730 hasAuthorship W4308187730A5008234338 @default.
- W4308187730 hasAuthorship W4308187730A5017368763 @default.
- W4308187730 hasAuthorship W4308187730A5046930712 @default.
- W4308187730 hasAuthorship W4308187730A5057116503 @default.
- W4308187730 hasConcept C126322002 @default.
- W4308187730 hasConcept C142724271 @default.
- W4308187730 hasConcept C167135981 @default.
- W4308187730 hasConcept C187212893 @default.
- W4308187730 hasConcept C2776136866 @default.
- W4308187730 hasConcept C2776336767 @default.
- W4308187730 hasConcept C2776804153 @default.
- W4308187730 hasConcept C2778426112 @default.
- W4308187730 hasConcept C2779134260 @default.
- W4308187730 hasConcept C3019118998 @default.
- W4308187730 hasConcept C71924100 @default.
- W4308187730 hasConcept C90924648 @default.
- W4308187730 hasConceptScore W4308187730C126322002 @default.
- W4308187730 hasConceptScore W4308187730C142724271 @default.
- W4308187730 hasConceptScore W4308187730C167135981 @default.
- W4308187730 hasConceptScore W4308187730C187212893 @default.
- W4308187730 hasConceptScore W4308187730C2776136866 @default.
- W4308187730 hasConceptScore W4308187730C2776336767 @default.
- W4308187730 hasConceptScore W4308187730C2776804153 @default.
- W4308187730 hasConceptScore W4308187730C2778426112 @default.
- W4308187730 hasConceptScore W4308187730C2779134260 @default.
- W4308187730 hasConceptScore W4308187730C3019118998 @default.
- W4308187730 hasConceptScore W4308187730C71924100 @default.
- W4308187730 hasConceptScore W4308187730C90924648 @default.
- W4308187730 hasIssue "5" @default.
- W4308187730 hasLocation W43081877301 @default.
- W4308187730 hasLocation W43081877302 @default.
- W4308187730 hasOpenAccess W4308187730 @default.
- W4308187730 hasPrimaryLocation W43081877301 @default.
- W4308187730 hasRelatedWork W1982912424 @default.
- W4308187730 hasRelatedWork W1986430299 @default.
- W4308187730 hasRelatedWork W2055320452 @default.
- W4308187730 hasRelatedWork W2325948386 @default.
- W4308187730 hasRelatedWork W2393353645 @default.
- W4308187730 hasRelatedWork W2415997520 @default.
- W4308187730 hasRelatedWork W2992647077 @default.
- W4308187730 hasRelatedWork W4213094776 @default.
- W4308187730 hasRelatedWork W4308187730 @default.
- W4308187730 hasRelatedWork W4365449356 @default.
- W4308187730 hasVolume "75" @default.
- W4308187730 isParatext "false" @default.
- W4308187730 isRetracted "false" @default.
- W4308187730 workType "article" @default.